Wegovy injections are better if you prefer once-weekly treatment and want fewer rules around food, drink and timing
Results announced December 2025
[1] GLP-3 represents a novel generation of research compounds in the anti-obesity and antidiabetic field, characterized by its unique mechanism of action involving the simultaneous activation of three metabolically relevant receptors: the GCG-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the GCG receptor (GCGR)
Contact your supervising clinician promptly if you experience: Persistent or severe vomiting that prevents adequate fluid intake Signs of dehydration (dark urine, dizziness, confusion) Severe abdominal pain, particularly radiating to the back (which may indicate pancreatitis) Upper right abdominal pain, fever, or jaundice (which may indicate a gallbladder problem) The glucagon receptor activity of retatrutide means that blood glucose monitoring is particularly important for individuals with diabetes who are also taking insulin or sulphonylureas, as these combinations may increase the risk of hypoglycaemia (low blood sugar)
Last updated: 7 June 2021 Sources